Patel, D. A., Shorr, A. F., Chastre, J., Niederman, M., Simor, A., Stephens, J. M., . . . Nathwani, D. (2014). Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Crit Care.
Citação norma ChicagoPatel, Dipen A., Andrew F. Shorr, Jean Chastre, Michael Niederman, Andrew Simor, Jennifer M. Stephens, Claudie Charbonneau, Xin Gao, and Dilip Nathwani. "Modeling the Economic Impact of Linezolid Versus Vancomycin in Confirmed Nosocomial Pneumonia Caused By Methicillin-resistant Staphylococcus Aureus." Crit Care 2014.
ציטוט MLAPatel, Dipen A., et al. "Modeling the Economic Impact of Linezolid Versus Vancomycin in Confirmed Nosocomial Pneumonia Caused By Methicillin-resistant Staphylococcus Aureus." Crit Care 2014.